A Real-World Study of Long-Term Safety and Efficacy of Lobeglitazone in Korean Patients with Type 2 Diabetes Mellitus.

Bo-Yeon Kim,Hyuk-Sang Kwon,Suk Kyeong Kim,Jung-Hyun Noh,Cheol-Young Park,Hyeong-Kyu Park,Kee-Ho Song,Jong Chul Won,Jae Myung Yu,Mi Young Lee,Jae Hyuk Lee,Soo Lim,Sung Wan Chun,In-Kyung Jeong,Choon Hee Chung,Seung Jin Han, Hee-Seok Kim, Ju-Young Min,Sungrae Kim

Diabetes & metabolism journal（2022）

引用 7|浏览13

暂无评分

摘要

Lobeglitazone has long-term safety profile, good glycemic-lowering effect and long-term durability of glycemic control in real-world clinical settings.

查看译文

关键词

Diabetes mellitus, type 2,Lobeglitazone,Observational study,Thiazolidinediones

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要